JAMA Network Home
Sign In
Editorial

Is Antigen-Specific Immunotherapy a New Frontier in HPV-Initiated Head and Neck Cancer?

JAMA Oncology 10.1001/jamaoncol.2026.3459

September 17, 2026 at 11:00 AM EDT

Read the full article

Corresponding Author: Barbara A. Burtness, MD, Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, 333 Cedar St, PO Box 208028, New Haven, CT 06520-8028 (barbara.burtness@yale.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2026.3459?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091726

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks